Singapore markets open in 6 hours 33 minutes

Vaccinex, Inc. (VCNX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.93-0.05 (-0.72%)
As of 12:49PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
50
570
275
900
50
-
Cost of revenue
-
-
-
0
2
199
Gross profit
-
-
-
900
48
324
Operating expenses
Research development
14,192
16,574
13,979
17,160
21,549
-
Selling general and administrative
6,163
6,881
6,202
6,230
7,405
-
Total operating expenses
20,355
23,455
20,181
23,390
28,379
-
Operating income or loss
-20,305
-22,885
-19,906
-22,490
-28,331
-
Interest expense
-14
1
2
809
489
-
Total other income/expenses net
923
2,635
93
919
-31
-
Income before tax
-19,368
-20,251
-19,815
-22,380
-28,851
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-19,368
-20,251
-19,815
-22,380
-28,851
-
Net income
-19,368
-20,251
-19,815
-22,380
-28,851
-
Net income available to common shareholders
-19,368
-20,251
-19,815
-22,380
-28,851
-
Basic EPS
-83.86
-43.68
-98.05
-163.80
-323.40
-
Diluted EPS
-83.86
-43.68
-98.05
-163.80
-323.40
-
Basic average shares
266.151
463.652
202.082
137.377
89.46
-
Diluted average shares
266.151
463.652
202.082
137.377
89.46
-